---
title: "中國誠通發展訂租賃資產轉讓協議  賺收入 447 萬人民幣"
description: "中國誠通發展集團公佈，與獨立第三方國耀融匯融資租賃訂立租賃資產轉讓協議，涉若干光伏發電設備、浮渣一體化分離機及滅菌器，購買價 1 億人民幣，租賃期兩年，租賃總額約 1.04 億人民幣。預計賺取收入 447 萬人民幣。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/251029917.md"
published_at: "2025-07-31T14:32:32.000Z"
---

# 中國誠通發展訂租賃資產轉讓協議  賺收入 447 萬人民幣

> 中國誠通發展集團公佈，與獨立第三方國耀融匯融資租賃訂立租賃資產轉讓協議，涉若干光伏發電設備、浮渣一體化分離機及滅菌器，購買價 1 億人民幣，租賃期兩年，租賃總額約 1.04 億人民幣。預計賺取收入 447 萬人民幣。

中國誠通發展集團 (00217.HK) 公佈，與獨立第三方國耀融匯融資租賃訂立租賃資產轉讓協議，涉若干光伏發電設備、浮渣一體化分離機及滅菌器，購買價 1 億人民幣，租賃期兩年，租賃總額約 1.04 億人民幣。預計賺取收入 447 萬人民幣。

### Related Stocks

- [00217.HK - 中國誠通發展集團](https://longbridge.com/zh-HK/quote/00217.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| China Chengtong Development Group Announces Major Leased Assets Transfer | China Chengtong Development Group Ltd. announced a Leased Assets Transfer Arrangement through its subsidiary, Chengtong  | [Link](https://longbridge.com/zh-HK/news/275469831.md) |
| China Chengtong Seals Major Leasing Transaction With PRC Finance Lessor | China Chengtong Development Group Limited (HK:0217) has arranged for its subsidiary, Chengtong Financial Leasing, to pur | [Link](https://longbridge.com/zh-HK/news/275477178.md) |
| China Chengtong Unit Enters Sale, Leaseback Arrangement With China KangFu | China Chengtong Unit Enters Sale, Leaseback Arrangement With China KangFu | [Link](https://longbridge.com/zh-HK/news/275549686.md) |
| Amazon, Google And Others Are Pouring $700 Billion Into AI CapEx, Top Analyst Explains Why This Makes It 'Hard' To Bet Against Nvidia | Amazon, Microsoft, Meta, Tesla, Apple, and Google are set to invest nearly $700 billion in AI-driven capital expenditure | [Link](https://longbridge.com/zh-HK/news/275700100.md) |
| CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | [Link](https://longbridge.com/zh-HK/news/276051793.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。